University of Utah Health | Posted Oct. 22 - 7:00 p.m.
| Save Story
Dr. Robert M. Silver has been a leader in stillbirth research, and his advocacy for patients and their families has helped fund and open U of U Health's Stillbirth Research Program and Pregnancy After Loss Program.
University of Utah Health | Posted Sept. 18 - 11:30 a.m.
| Save Story
Changes in sports have resulted in an increasing number of overuse injuries and burnout. These evolving challenges are often based on the trend to get kids into sports specialization at an earlier age.
University of Utah Health | Posted June 26 - 8:00 a.m.
| Save Story
An estimated 80% of Americans could be dealing with foot pain. Whether you like waking, hiking, running, or playing recreational sports, proper foot care and footwear will make it easier and more comfortable to enjoy the season.
University of Utah Health | Posted May 8 - 1:14 p.m.
| Save Story
Utah health professionals are increasing their commitment to improving the treatment and understanding of the mental health challenges experienced by women during and after a pregnancy.
University of Utah Health | Posted March 27 - 8:00 a.m.
| Save Story
Health care providers here in Utah already see plenty of evidence that reflects a spike in the rates of children with obesity during COVID-19 lockdowns.
University of Utah Health | Posted Feb. 27 - 8:00 a.m.
| Save Story
A recent social media phenomenon has teen and tween girls as young as 9 years old obsessed with caring for their skin. Parents wonder if it is a healthy obsession.
University of Utah Health | Posted Dec. 27 - 3:00 p.m.
| Save Story
Doctors hope FDA approval of a pill for postpartum depression called Zuranolone (under the brand name Zurzuvae) could raise awareness and increase treatment options for this debilitating condition.
University of Utah Health | Posted Nov. 29 - 8:48 a.m.
| Save Story
While a cure for dementia eludes doctors and scientists, the push is on to identify new strategies and treatments that might work to prevent or delay the onset of the disease.
University of Utah Health | Posted Oct. 25 - 8:00 a.m.
| Save Story
Doctors hope FDA approval of a pill for postpartum depression called Zuranolone (under the brand name Zurzuvae) could raise awareness and increase treatment options for this debilitating condition.